The Swiss Trader
The Swiss Trader
Stop FollowingThe Swiss Trader
View as an RSS Feed
View The Swiss Trader's Articles BY TICKER:
- Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
- 2 Biotech Companies With Strong Product Launches To Monitor
- Profits Can Be Found In The Expanding And Challenging Medical Isotope Business
- 3 Contenders With Novel, Non-Invasive Treatments For Cancer
- Biotechnology Super Panel Talks Development, Marketing And The Future
- Recent Melanoma Trial Data Has Biotech Stocks Moving
- Buy Low, Sell High - Apache Is Undervalued At Under $75
- New Regulations To Phase Out HEU Radioisotopes May Phase In Money For Investors
- EMC Ready To Rise On Big Data Analytics
- 2012 Stem Cell Standouts And The Outlook For 2013
- Rio Tinto: A Smart Play On Iron Ore Market Growth In 2013
- Extending Lives Through Nuclear Medicine May Also Extend Investors' Profits
- Stem Cell Companies For Consideration In 2013
- Galena Removes Financing Risk
- Celsion To Open The Door For Medical Device Companies Following Its Success
- Targeted Radiation Looks To Create And Grow Revenue
-
NeoStem Awarded $1.2 Million Grant For VSEL Development
- An Exciting Week In Cell Therapy
- Apache Looks Ready To Climb On Increased Production
- A Change In Supply To Meet Isotope Demand
- After A Data-Packed October, What Will November Bring For NeoStem?
- 3 Companies With Promising New Cancer Treatments
- Will Production At Agnico-Eagle Mines Outmatch Price Increases This Quarter?
- 5 Biotech Companies With Major Market-Moving Announcements To Start The Week
-
Assessing Peregrine And Seeking Upside In The Space
-
3 Pharmaceuticals Pursuing Non-Surgical Approaches To Combating Cancer
- Profit From A Global Turnaround By Buying BHP Billiton Today
- NeoStem: A Promising Investment Candidate In Stem Cell Treatment
- A Diverse Group Of Pharmaceuticals With Good Upside Potential
- White House Stance On Medical Isotopes May Leave Foreign Producers Nuked
- Cell Therapy Outlook Starting To Match Clinical Results
- Small-Cap Adjuvants For Cancer Treatment
